Effect of Ruboxistaurin in Patients With Diabetic Macular Edema
Author:
- PKC-DMES Study GroupPGPKC-DMES Study Group
- 1 March 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 125 (3) , 318-324
Abstract
Research from JAMA Ophthalmology — Effect of Ruboxistaurin in Patients With Diabetic Macular Edema — Thirty-Month Results of the Randomized PKC-DMES Clinical TrialKeywords
This publication has 16 references indexed in Scilit:
- Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412Investigative Ophthalmology & Visual Science, 2004
- Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic ratsCurrent Eye Research, 2004
- Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic ComplicationsCurrent Topics in Medicinal Chemistry, 2002
- Effects of the protein kinase Cβ inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetesClinical Science, 2002
- Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin StudyActa Ophthalmologica Scandinavica, 1999
- The extended protein kinase C superfamilyBiochemical Journal, 1998
- Vascular Endothelial Growth Factor-Induced Retinal Permeability is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform-Selective Inhibitor.Retina, 1998
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reformDiabetes Care, 1994
- Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House ClassificationOphthalmology, 1991